Craniospinal Irradiation Dose De‐Escalation With Chemotherapy in Pediatric Standard‐Risk Medulloblastoma: A Systematic Review and Meta‐Analysis
Pediatric Blood & Cancer · 20.11.2026
DOI: 10.1002/1545-5017.70843 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 20.11.2026. Verfasst von Juan Sebastian Solis‐Mata und 4 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Craniospinal irradiation (CSI) plus chemotherapy is standard for pediatric standard/average‐risk medulloblastoma, but the safest de‐escalated dose remains uncertain. We systematically reviewed four databases and meta‐analyzed 5‐year disease‐control survival (DCS) and overall survival (OS). Fifteen studies were included. Modern 18/23.4‐Gy CSI yielded 79.6% DCS and 85.3% OS. At 23.4 Gy, corresponding estimates were 81.0% and 86.7%; at 18 Gy, 71.3% and 79.1%. Current evidence supports 23.4 Gy as the most reproducible platform, whereas routine 18‐Gy use is not supported outside prospectively selected, molecularly favorable populations.
Zitieren
APA
Solis‐Mata, J. S., Moreno, M. F. M., Gudiño‐Alvarez, D. A., Oblitas, J. H. R., & Habif, O. B. (2026). Craniospinal Irradiation Dose De‐Escalation With Chemotherapy in Pediatric Standard‐Risk Medulloblastoma: A Systematic Review and Meta‐Analysis. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70843
Vancouver
Solis‐Mata JS, Moreno MFM, Gudiño‐Alvarez DA, Oblitas JHR, Habif OB. Craniospinal Irradiation Dose De‐Escalation With Chemotherapy in Pediatric Standard‐Risk Medulloblastoma: A Systematic Review and Meta‐Analysis. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70843
BibTeX
@article{SolisMata2026,
author = {Solis‐Mata, Juan Sebastian and Moreno, Maria Fernanda Moreno and Gudiño‐Alvarez, Diego Antonio and Oblitas, Jose Hernan Rojas and Habif, Orly Braverman},
title = {Craniospinal Irradiation Dose De‐Escalation With Chemotherapy in Pediatric Standard‐Risk Medulloblastoma: A Systematic Review and Meta‐Analysis},
journal = {Pediatric Blood & Cancer},
year = {2026},
doi = {10.1002/1545-5017.70843}
}
EUVIMED